Cannabis Retailers Can Expect ‘Massive’ Sales Day on 4/20

April 19, 2023 · Green Market Report

Social consumption is also on the rise.

The unofficial cannabis holiday of April 20 – better known as 4/20 – is tomorrow, and retailers should be prepared for a “massive” sales day, according to tech firms that have tracked sales in past years.

“This is the Super Bowl for the industry,” said Socrates Rosenfeld, the CEO of California-based I Heart Jane, a tech platform that helps marijuana retailers facilitate sales. “It’s our Black Friday.”

Rosenfeld said that despite headwinds in the cannabis industry in recent months, there’s been no indication that marijuana consumption rates have slowed down, and so he’s expecting yet another enormous sales day this year, which cannabis retailers in mature markets have come to expect.

“Overall, you’ll see at least a 100% increase in sales on that day, and I think it’s safe to say it’s across all retailers,” Rosenfeld predicted, adding that 4/20 is usually about 50% more in terms of sales volume than the second-busiest sales day of the year.

“It’s how much they’re participating and leaning into it: Are they running deals and specials? Are they doing events and things like that leading up to 4/20? Have they prepared from a digital standpoint to have the biggest reach? Those are the factors that are going to correlate to higher sales,” Rosenfeld said, when asked if there are any particularly successful strategies that retailers have used to attract customers on 4/20.

According to data shared by I Heart Jane, as well as from Colorado-based cannabis data firm BDSA, 4/20 last year set a new benchmark for most state markets, with sales increasing pretty much across the board from 2021 – particularly in newer markets.

This year could be even bigger, given that 4/20 falls on a Thursday. Last year, 4/20 arrived on a Wednesday, which is traditionally a slower retail sales day, both Rosenfeld and BDSA said.

Retailers that aren’t properly prepared for huge crowds, Rosenfeld warned, could ultimately lose customers to competing shops.

Last year, there was an overall year-over-year increase in product sales of 35% on I Heart Jane’s platform, and Rosenfeld singled out edibles and vape cartridges as particularly popular product categories. The company serves roughly 2,500 cannabis retailers across 38 states and Canada.

The 4/20 sales data analysis from I Heart Jane from 2021 to 2022 found:

  • 34% increase in edibles sales.
  • 43% increase in vape cartridge sales.
  • 22% increase in raw cannabis flower sales.
  • 10% increase in extracts sales.

But data from sources also showed that in some older markets – such as California and Colorado – the cannabis holiday didn’t necessarily mean a big boost in sales for retailers.

“The impact of the holiday differs significantly when comparing mature markets and emerging markets,” BDSA wrote in a statement.

The company noted that in emerging markets – including Arizona, Florida, Illinois, Maryland, Missouri, New Jersey, and Pennsylvania – 4/20 sales last year were up 134% from other average days in the same month. By contrast, sales in mature markets – including California, Colorado, Massachusetts, Michigan, Nevada, and Oregon – were up 114% by the same metric.

And according to I Heart Jane, California and Colorado last year even saw sales decreases on average from 4/20 in 2021, at -15% and -20% respectively, compared to Arizona and Illinois, where sales increased 100% and 54% respectively last year on 4/20 from the year prior.

That said, BDSA emphasized that even mature market cannabis retailers are still likely to see a sales bump compared to average sales days in April and the rest of the year. In California, Michigan, and Oregon, 4/20 sales last year hit 138% of non-holiday sales days for the same month.

Getting Social

BDSA also reported that social consumption is “on the rise after taking a hit during the pandemic,” and predicted that 4/20 will bolster that trend, which could have longer-term ramifications for new and upcoming consumption lounge businesses in various states.

A survey from Ayr Wellness (CSE: AYR.A) (OTCQX: AYRWF) noted that 40% of cannabis consumers already had plans to take 4/20 off this year.

“Small get-togethers” was cited by just 49% of consumers surveyed by BDSA as a reason for cannabis consumption in the spring of 2021 when the COVID-19 pandemic was still in full swing, but that number spiked to 62% in the company’s most recent consumer study.

That, combined with the wide swath of product deals and discounts that retailers offer in advance of 4/20, is a good indicator that this year will again attract immense levels of customers, BDSA predicted.

“The myriad of deals on the 420 holiday are likely to attract consumers even if they do not plan on burning down a fatty with their friends,” BDSA quipped in its report. (Full Story)

In categories:Business Uncategorized
Next Post

Americans now spend MORE on legal weed than on chocolate: Sales of marijuana from dispensaries topped $30billion in the last year compared to $18billion on the sweet stuff

Americans spent more money on legal weed last year than chocolate and craft beer combined after major changes to marijuana laws, a new report has revealed.  Tapped at $30billion by cannabis website MJBizDaily, the monetary measure of legal marijuana sales increased by more…
Previous Post

Green Market Report Women’s Leadership Awards: Rachel Edwards

Rachel Edwards heads research and development for Statehouse Holdings. Best Cultivation: Rachel Edwards, Statehouse Holdings Statehouse Holdings (CSE: STHZ), a leading player in the California cannabis industry, has made great strides under the guidance of its research and development manager, Rachel…
Random Post

Nevada Senators Discuss Psilocybin Legalization Bill In Committee, Including Amendment To Increase Possession Limit

Nevada senators held a hearing on a bill to legalize the possession of psilocybin on Thursday, discussing a proposed amendment to remove therapeutic use provisions and taking extensive testimony from advocates and experts—including from an Assembly lawmaker who shared his…
Random Post

Awakn Life Sciences' Revenue up 534% in 2022, AUD Treatment Advances

The firm has made meaningful strides in its early clinical runway as it gears up for government-funded studies. Toronto-based Awakn Life Sciences Corp. (OTC: AWKNF), a biotech company focused on addiction treatments, reported a heft 534% rise in annual revenue for the…
Random Post

Marijuana MSOs sue New York over adult-use retail license delay

Multistate operators with New York medical cannabis licenses sued regulators on Thursday in an attempt to gain quick entry into the state’s adult-use marijuana market. The MSOs are currently shut out from New York’s legal recreational market. In a lawsuit filed in…
Random Post

Texas Medical Marijuana Expansion in Legislative Limbo as Session Nears End

Any bills still in committee on Wednesday will be dead in the water. The future of medical cannabis expansion in Texas remains uncertain, as the state’s legislative session is set to conclude this Memorial Day. Crucial legislation aiming to broaden…